Sales and marketing representatives in the life science industry must comply with state and federal regulations. What are these regulations and how should you navigate them? Join Darshan Kulkarni as he talks with Marc Banjak, General Counsel at Dova...
Pharmaceutical companies have spent billions of dollars in an effort to create COVID-19 vaccines and drugs. Should the federal government force these companies to offer their products for free? Join Darshan Kulkarni as he talks with guest Doug...
Marketing and medical affairs are often perceived as being separate. What happens when drug companies market their own products? Join Darshan Kulkarni as he talks with guest Dr. Stephen Towers about the intersection between marketing and medical...
Blockchain technology has become an increasingly common tool for life science organizations. How is this technology being used by life science companies? Join Darshan Kulkarni as he talks with guest Jim Nasr about the use of distributed ledger...
Publications are a central part of medical affairs. What is publication planning, and what are some common mistakes associated with it? Join Darshan Kulkarni as he talks with Head of Medical Affairs and Operations Elisabeth Fine about the major...
How should you name your drug? Join Darshan Kulkarni as he talks with trademark lawyer Donna Tobin about the importance of performing a trademark search when naming your drug. Plus, we’ll discuss the advantages of performing a knockout search.
